Site Search

... sure more residents of Hawai'i can benefit from this important testing. Video of maggies_biomarker_story   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

... from patients to identify and evaluate cancer biomarkers. Testing patients for specific biomarkers is integral to precision medicine in cancer care, but despite evidence pointing to the clinical benefits associated with biomarker testing, routine clinical use does not always follow, and ... insurance would not cover it or their out-of-pocket costs would be too high. A new report by ACS CAN and LUNGevity Foundation found while health insurance coverage for biomarker testing has improved since the organizations’ last report in 2018, coverage is still failing to keep up ... a combination of factors, as highlighted in the ACS CAN report  Improving Access to Biomarker Testing - Advancing Precision Medicine in Cancer Care  which explores the current landscape of cancer biomarker testing, sheds light on the nature of challenges limiting adoption of appropriate ...

... and successfully underwent testing after her insurance company denied coverage for testing. “Biomarker testing was a gamechanger in my cancer care,” said Dennis. “Knowing my results informed my team of doctors to the best treatments options possible. Even more Coloradans should ... more Coloradans have access to testing when they need it.” Under SB24-124, over one million Coloradans or roughly 33% of those with private health insurance coverage will now benefit from improved coverage for biomarker testing. Unfortunately, the law does not include coverage for Medicaid enrollees which accounts for more than 1.6 million Coloradans, according to the Department of Health Care Policy and Financing.  “While today is a win for Coloradans who are battling cancer and other diseases, it’s important we ...

... treatment at the right time. While its application has predominantly been in oncology, the power of biomarker testing extends beyond cancer care to the treatment of diseases such as arthritis, other autoimmune conditions and rare diseases. And so, a robust, disease-agnostic coalition ... relations director for ACS CAN in Delaware, responded, “Today’s vote brings Delaware patients one step closer to accessing the personalized care they need without worrying about whether their insurance will cover the testing that can guide critical treatment decisions. We are grateful ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer ...